Seven-day open-source intelligence view for European Union, including reporting, hazards, cyber and network signals.
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised
Start of procedure: Extension of marketing authorisation (18 September 2026 - 15 October 2026)
CHMP PROM minutes for the meeting on 13 April 2026
As the colder months approach in Europe, respiratory infections including influenza, respiratory syncytial virus (RSV) infections, COVID-19, pneumococcal disease and others can lead to serious illness and increase the burden on healthcare services throughout…
As the colder months approach in Europe, respiratory infections including influenza, respiratory syncytial virus (RSV) infections, COVID-19, pneumococcal disease and others can lead to serious illness and increase the burden on healthcare services throughout…
On 21 October 2026, GitLab published a security advisory addressing several vulnerabilities among which a critical flaw that could allow an unauthenticated user to execute arbitrary code on a GitLab server. CERT-EU recommends organisations to update affected…
Video: 00:00:49 ESA Open Days 2026 welcomed over 23 000 visitors across its six establishments, giving the public the opportunity to discover more about Europe’s space activities, meet the people behind the missions and explore how ESA is shaping the future o…
The European Space Agency Council has approved the appointment of two new directors: Andrzej Banasiak as Director of Commercialisation and Industry Partnership, and Nicolaus Hanowski as Director of Space Operations.